Abnormal regulation of SLE andMAPK metabolic pathways might have a significant impact on the occurrence of MI.CYP4F3/TBL1XR1/GBGT1/USP25/FDFT1/RORA expression could possiblybe used as markers for the diagnosis of AMI, and hopefully, suggest new methods whenbeing used as clinical targets for the treatment of AMI patients. This evidence concerns the gene USP25 and myocardial infarction.